Our study population consisted of 574 patients with chronic viral hepatitis (CHB or CHC), who were examined over a seven year period (from 1 January 2007 to 31 September 2013) in the Hepatology outpatient unit of a General Hospital of Athens -Greece. Five hundred and forty nine out of 574 (95.6%) patientsmet the inclusion criteria and constituted our final study sample.